A good article in BNA by Eric W. Schweibenz and Lisa M.
Mandrusiak argues that the recent trend in trade secret
litigation has been to require plaintiffs to state with
specificity early in litigation what trade secrets
they claim the defendants stole. This prevents
"fishing expeditions," where plaintiffs bring vague
claims for misappropriation of trade secrets in the hope that
they'll find something solid when they obtain documents and
other information from defendants in discovery. It also
helps defendants decide what is relevant when
responding to discovery requests from plaintiffs
and helps defendants prepare a defense. Ultimately, the
requirement can help resolve cases faster because the defendants
know earlier what the case is about and the strength of their
This requirement should make employers that are considering
suing former employees for misappropriation of trade secrets think
before they file. I've
written about this before, but it bears repeating: if an
employer is going to accuse an employee of stealing trade
secrets, it better have a good idea of what those trade
secrets are. If the employer doesn't, that fact can
really slow down, and even stop, a case before it really
gets started, and the employer will lose a good deal of credibility
in the judge's eyes.
To view Foley Hoag's Massachusetts Noncompete Law
Blog please click
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Foley Hoag will present a 60-minute webinar on Wednesday, January 25, 2017 at 12:30 pm EST offering guidance to in-house counsel on best practices for pharmaceutical and biologics companies in selecting, vetting, and seeking approval for medication product names. The focus will be primarily on the U.S. market, although foreign strategies may be addressed as well.
25 Jan 2017, Seminar, Massachusetts, United States
Please join us on Wednesday, January 25 at the Westin Waltham Hotel for our quarterly New England M&A Forum, which brings the latest in market trends and recent legal developments to the New England M&A professionals' community.
Sellers love them, buyers hate them, but auctions are a mainstay of the M&A landscape. Our panel of experts, led by Foley Hoag partner Bill Kolb, will discuss legal, business and strategic considerations in structuring and participating in auctions from both the buy-side and the sell-side.
Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
In June 2016, the NHL announced that Las Vegas would be awarded an NHL franchise team, the first major professional sports team in the city and the first new expansion team for the NHL in over fifteen years.
On December 6, 2016, the parties to the complex and soon-to-be departed world of patent interferences orally argued their positions on motions in what has been described as the "biotech trial of the century"...
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).